US moves to sell gene-edited mushrooms fuel doubts over British ban on GM imports
By Robin McKie,
The Guardian
| 04. 23. 2016
Untitled Document
American regulators have allowed the cultivation and sale of two crops modified with the gene-editing technique known as Crispr. The crops – a white button mushroom and a form of corn – are the first Crispr plants to be permitted for commercial use in the US.
The move is a boost for new technology in the creation of foodstuffs, but is expected to worsen the considerable confusion in Britain over the use of gene-editing in agriculture and the importing of crops created using such technology.
A committee of European commission regulators was expected to report last month on whether gene-edited crops should be classed as genetically-modified organisms or should be freed from the severe restrictions concerning GMOs in Europe. At the last minute it announced a delay in its verdict – to the dismay of many UK scientists.
“The committee knew it would be highly controversial, no matter what decision it made, so they have kicked the issue into the long grass, and that is very damaging,” said crop scientist Professor Huw Jones of Aberystwyth university.
“Researchers...
Related Articles
By Adam Feuerstein, Stat | 11.20.2025
The Food and Drug Administration was more than likely correct to reject Biohaven Pharmaceuticals’ treatment for spinocerebellar ataxia, a rare and debilitating neurodegenerative disease. At the very least, the decision announced Tuesday night was not a surprise to anyone paying attention. Approval...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...
By Patrick Foong, BioNews | 11.03.2025
By Heidi Ledford, Nature | 10.31.2025
Late last year, dozens of researchers spanning thousands of miles banded together in a race to save one baby boy’s life. The result was a world first: a cutting-edge gene-editing therapy fashioned for a single person, and produced in...